Catalyst Crew Technologies Corp. (OTC: CCTC), an artificial intelligence-driven healthcare technology company, announced that its Chief Executive Officer, Kevin Roldan Levy, has initiated a capital structure initiative. Under this plan, up to fifty percent of his restricted common stock holdings will be canceled in exchange for a newly designated class of preferred equity. This move is intended to optimize the company's common equity base, enhance long-term strategic flexibility, and align executive equity participation with broader corporate development goals.
The company believes that upon implementation, the transaction will contribute to a more disciplined equity framework and support its evolving long-term strategic initiatives, including future financing opportunities, strategic partnerships, and broader operational development. The initiative is also expected to strengthen alignment between executive leadership and long-term corporate performance objectives while reinforcing management's commitment to disciplined growth and shareholder-oriented development.
"This initiative reflects my long-term commitment to the Company's strategic development and disciplined capital structure management," said Kevin Roldan Levy. "As we continue advancing our broader healthcare technology strategy, I believe proactive capital structure planning will support stronger long-term positioning while reinforcing our commitment to sustainable shareholder value creation."
The company is currently finalizing the structure and designation of the new preferred equity as part of the implementation process and expects to provide additional updates as final corporate actions are completed. Catalyst Crew continues to advance its transition into AI-enabled healthcare, with a focus on telehealth infrastructure, remote patient monitoring, and data-driven clinical insights across underserved markets.
Catalyst Crew Technologies is an AI-driven healthcare technology company focused on scalable digital health solutions for emerging markets, with an initial emphasis on Latin America. The company is actively executing its strategic transition into AI-enabled healthcare and pursuing opportunities across telehealth infrastructure, remote patient monitoring, healthcare data analytics, and integrated digital care platforms. For more information, visit https://catalystcrewai.com or review the company's filings with the U.S. Securities and Exchange Commission at www.sec.gov.
